354 related articles for article (PubMed ID: 16273638)
61. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.
Prado-Garcia H; Aguilar-Cazares D; Meneses-Flores M; Morales-Fuentes J; Lopez-Gonzalez JS
Cancer Immunol Immunother; 2008 Mar; 57(3):325-36. PubMed ID: 17668204
[TBL] [Abstract][Full Text] [Related]
62. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.
Uzzo RG; Rayman P; Kolenko V; Clark PE; Bloom T; Ward AM; Molto L; Tannenbaum C; Worford LJ; Bukowski R; Tubbs R; Hsi ED; Bander NH; Novick AC; Finke JH
Clin Cancer Res; 1999 May; 5(5):1219-29. PubMed ID: 10353760
[TBL] [Abstract][Full Text] [Related]
63. Death of solid tumor cells induced by Fas ligand expressing primary myoblasts.
Hofmann A; Blau HM
Somat Cell Mol Genet; 1997 Jul; 23(4):249-57. PubMed ID: 9542527
[TBL] [Abstract][Full Text] [Related]
64. [The evaluation of Fas/Fas ligand system in renal cell carcinoma--the effect of preoperative interferon-alpha therapy].
Sejima T; Miyagawa I
Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):826-32. PubMed ID: 10565161
[TBL] [Abstract][Full Text] [Related]
65. Immunohistochemical analysis of Fas ligand expression in sarcomas. Sarcomas express high level of FasL in vivo.
Lee SH; Jang JJ; Lee JY; Kim SY; Park WS; Kim CS; Kim SH; Yoo NJ
APMIS; 1998 Nov; 106(11):1035-40. PubMed ID: 9890264
[TBL] [Abstract][Full Text] [Related]
66. Aberrant Fas ligand expression in lymphocytes in patients with Behçet's disease.
Wakisaka S; Takeba Y; Mihara S; Takeno M; Yamamoto S; Sakane T; Suzuki N
Int Arch Allergy Immunol; 2002 Oct; 129(2):175-80. PubMed ID: 12403936
[TBL] [Abstract][Full Text] [Related]
67. A modification of the JAM test is necessary for a correct determination of apoptosis induced by FasL+ adherent tumor cells.
Böhm C; Hanski ML; Gratchev A; Mann B; Moyer MP; Riecken EO; Hanski C
J Immunol Methods; 1998 Aug; 217(1-2):71-8. PubMed ID: 9776576
[TBL] [Abstract][Full Text] [Related]
68. Expression of Fas ligand in gastric carcinoma relates to lymph node metastasis.
Nagashima H; Mori M; Sadanaga N; Mashino K; Yoshikawa Y; Sugimachi K
Int J Oncol; 2001 Jun; 18(6):1157-62. PubMed ID: 11351245
[TBL] [Abstract][Full Text] [Related]
69. Functional investigation of Fas ligand expressions in human non-small cell lung cancer cells and its clinical implications.
Lin Y; Liu L; Zhang T; Liu J
Ann Thorac Surg; 2013 Feb; 95(2):412-8. PubMed ID: 23021303
[TBL] [Abstract][Full Text] [Related]
70. [Immune evasion of human lung carcinoma cell A549 suppressed by human lymphoma cell Jurkat via Fas/FasL pathway].
Wang H; Zhang G; Dai J; Min J
Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):681-5. PubMed ID: 20673483
[TBL] [Abstract][Full Text] [Related]
71. Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival.
Xu G; Zhang J
J Cancer Res Clin Oncol; 2008 Oct; 134(10):1043-9. PubMed ID: 18461366
[TBL] [Abstract][Full Text] [Related]
72. Enhanced cell death in NR-S1 tumor by photodynamic therapy: possible involvement of Fas and Fas ligand system.
Yokota T; Ikeda H; Inokuchi T; Sano K; Koji T
Lasers Surg Med; 2000; 26(5):449-60. PubMed ID: 10861700
[TBL] [Abstract][Full Text] [Related]
73. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
Shukuwa T; Katayama I; Koji T
Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
[TBL] [Abstract][Full Text] [Related]
74. Fas/Fas ligand expression and characteristics of primed CD45RO+ T cells in the inflamed mucosa of ulcerative colitis.
Suzuki A; Sugimura K; Ohtsuka K; Hasegawa K; Suzuki K; Ishizuka K; Mochizuki T; Honma T; Narisawa R; Asakura H
Scand J Gastroenterol; 2000 Dec; 35(12):1278-83. PubMed ID: 11199367
[TBL] [Abstract][Full Text] [Related]
75. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
Yao H; Song E; Chen J; Hamar P
Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
[TBL] [Abstract][Full Text] [Related]
76. Retinoic acid morpholine amide (RAMA) inhibits expression of Fas ligand through EP1 receptor in colon cancer cells.
Chen SX; Du SY; Wang YT; Zhao HC; Zhang YL; Yao L
Tumour Biol; 2016 Jan; 37(1):323-9. PubMed ID: 26211005
[TBL] [Abstract][Full Text] [Related]
77. Fas and Fas ligand expression in pancreatic adenocarcinoma.
Pernick NL; Sarkar FH; Tabaczka P; Kotcher G; Frank J; Adsay NV
Pancreas; 2002 Oct; 25(3):e36-41. PubMed ID: 12370548
[TBL] [Abstract][Full Text] [Related]
78. Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen.
Mor G; Kohen F; Garcia-Velasco J; Nilsen J; Brown W; Song J; Naftolin F
J Steroid Biochem Mol Biol; 2000; 73(5):185-94. PubMed ID: 11070347
[TBL] [Abstract][Full Text] [Related]
79. Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines.
Rajashekhar G; Loganath A; Roy AC; Mongelli JM
Gynecol Oncol; 2003 Oct; 91(1):101-11. PubMed ID: 14529668
[TBL] [Abstract][Full Text] [Related]
80. Apoptosis induced in T cells by human neuroblastoma cells: role of Fas ligand.
Shurin GV; Gerein V; Lotze MT; Barksdale EM
Nat Immun; 1998; 16(5-6):263-74. PubMed ID: 11061594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]